Impact of Immunotherapy on Autoimmune Skin Diseases

This chapter examines the effects of medications like TNF inhibitors and immune checkpoint inhibitors on skin diseases such as cutaneous lupus and dermatomyositis. It emphasizes the role of type 1 interferon in immune reactions and discusses how patient histories concerning supplements and vaccinations can influence treatment outcomes. Furthermore, it explores ongoing research into targeted therapies and the involvement of plasmacytoid dendritic cells in managing these autoimmune conditions.